Abstract 753: Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer
Grant A. Howe(University of Ottawa), Christina Addison(Ontario Institute for Cancer Research), Glenwood Goss(Ottawa Hospital), Bin Xiao(Ottawa Hospital), Huijun Zhao(Ministry of Education of the People's Republic of China)
Cited by 0
Related Papers
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
Silver-Catalyzed Ring-Opening Strategy for the Synthesis of β- and γ-Fluorinated Ketones
|Journal of the American Chemical Society|2015|379
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
|The Lancet Oncology|2017|222
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
|Nature Medicine|2015|169